Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 5
2006 9
2007 12
2008 11
2009 5
2010 9
2011 11
2012 16
2013 19
2014 21
2015 31
2016 22
2017 11
2018 20
2019 26
2020 14
2021 14
2022 14
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I, Xia CW, Besoiu S, Finkel PL, Ellis SLS, Kari S, Munro L, Pfeifer CG, Fazli L, Gleave ME, Jefferies WA. Saranchova I, et al. Among authors: fazli l. Front Immunol. 2024 Mar 7;15:1317522. doi: 10.3389/fimmu.2024.1317522. eCollection 2024. Front Immunol. 2024. PMID: 38524132 Free PMC article.
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.
Kaarijärvi R, Kaljunen H, Nappi L, Fazli L, Kung SHY, Hartikainen JM, Paakinaho V, Capra J, Rilla K, Malinen M, Mäkinen PI, Ylä-Herttuala S, Zoubeidi A, Wang Y, Gleave ME, Hiltunen M, Ketola K. Kaarijärvi R, et al. Among authors: fazli l. Commun Biol. 2024 Jan 18;7(1):108. doi: 10.1038/s42003-023-05741-x. Commun Biol. 2024. PMID: 38238517 Free PMC article.
Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.
Ma T, Jin L, Bai S, Liu Z, Wang S, Shen B, Cho Y, Cao S, Sun MJS, Fazli L, Zhang D, Wedderburn C, Zhang DY, Mugon G, Ungerleider N, Baddoo M, Zhang K, Schiavone LH, Burkhardt BR, Fan J, You Z, Flemington EK, Dong X, Dong Y. Ma T, et al. Among authors: fazli l. J Natl Cancer Inst. 2024 Mar 7;116(3):421-433. doi: 10.1093/jnci/djad215. J Natl Cancer Inst. 2024. PMID: 37847647
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.
Yenki P, Bhasin S, Liu L, Nabavi N, Cheng CW, Tam KJ, Peacock JW, Adomat HH, Tombe T, Fazli L, Ivanova L, Dusek C, Khosravi S, Guns EST, Wang Y, Buttyan R, Gleave ME, Ong CJ. Yenki P, et al. Among authors: fazli l. Endocr Relat Cancer. 2023 Nov 6;30(12):e230010. doi: 10.1530/ERC-23-0010. Print 2023 Dec 1. Endocr Relat Cancer. 2023. PMID: 37800655 Free PMC article.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L, Gleave M, Hurtado-Coll A, Thompson IM, Troyer D, McKenney JK, Wei W, Choyke PL, Bratslavsky G, Turkbey B, Siemens DR, Squire J, Peng YP, Brooks JD, Jamaspishvili T. Patel P, et al. Among authors: fazli l. Mod Pathol. 2023 Oct;36(10):100241. doi: 10.1016/j.modpat.2023.100241. Epub 2023 Jun 19. Mod Pathol. 2023. PMID: 37343766
Robust Nanoparticle-Derived Lubricious Antibiofilm Coating for Difficult-to-Coat Medical Devices with Intricate Geometry.
Yazdani-Ahmadabadi H, Yu K, Khoddami S, F Felix D, Yeh HH, Luo HD, Moskalev I, Wang Q, Wang R, Grecov D, Fazli L, Lange D, Kizhakkedathu JN. Yazdani-Ahmadabadi H, et al. Among authors: fazli l. ACS Nanosci Au. 2022 Oct 28;3(1):67-83. doi: 10.1021/acsnanoscienceau.2c00040. eCollection 2023 Feb 15. ACS Nanosci Au. 2022. PMID: 36820095 Free PMC article.
254 results